{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-001271","form_type":"8-K","ticker":"SBEV","cik":"0001553788","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-09-22T20:10:25+00:00","discovered_at":"2026-09-22T20:11:19.347554+00:00","generated_at":"2026-09-22T20:11:26.963583+00:00","sec_items":["7.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Endovia closes $500K convertible debt financing from C/M Capital for CannEpil development","bullets":["Closed $500,000 initial secured convertible debt from C/M Capital Master Fund, LP; first tranche of $1M commitment.","Funds support CannEpil® FDA veterinary program (INAD File No. 14145) and international commercialization.","Partner Lupvindol Biosciences Ltd. advancing canine oncology pain program; exclusive global rights from Argent BioPharma.","H.R. 10150 (introduced Aug 27, 2026) proposes 12-year market exclusivity for FDA-approved botanical drugs.","FDA launched initiative on botanical drug development; company cites growing federal support for cannabis-derived therapies."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-001271","json":"https://secwatch.observer/filing/0001731122-26-001271.json","markdown":"https://secwatch.observer/filing/0001731122-26-001271.md","text":"https://secwatch.observer/filing/0001731122-26-001271.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226001271/0001731122-26-001271-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226001271/e7964_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-22T20:11:26.963583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}